BRD7 was initially identified as a tumor suppressor in NPC by involved in multiple pathways such as ras/MEK/ERK, Rb/E2F, and Wnt/beta-catenin, and might be a prognostic biomarker28,29. The gene discussed is BRD7; the disease is nasopharyngeal carcinoma.